2 completed, 2 unknown, 1 active not recruiting, 1 withdrawn. 6 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 6 | Completed 2, Unknown 2, Active not recruiting 1, Withdrawn 1 |
Follow Coronary Aneurysm: new trials by email Literature Review of Coronary Aneurysm trials Research Report on Coronary Aneurysm
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Antithrombotic Therapy in Acute Coronary Syndromes and Coronary Artery Ectasia Rivaroxaban 15 MG, Acetylsalicylic acid 100mg, Clopidogrel 75 Mg Oral Tablet - Acute Coronary Syndrome, Coronary Artery Ectasia | Phase 2 | Unknown | Instituto Nacional de Cardiologia Ignacio Chavez | 60 | 2021-09-01 | 2022-02-10 |
| Study of Efficacy and Safety of Canakinumab in Pediatric Patients With Kawasaki Disease Canakinumab - Kawasaki Disease | Phase 2 | Withdrawn | Novartis Pharmaceuticals | 2016-11-15 | 2017-02-17 | |
| Anakinra and Kawasaki Disease Anakinra - Kawasaki Disease, Children | Phase 2 | Completed | Assistance Publique - Hôpitaux de Paris | 16 | 2016-02-05 | 2019-07-02 |
| Doxycycline Treatment to Prevent Progressive Coronary Artery Dilation in Children With Kawasaki Disease Doxycycline, Placebo - Kawasaki Disease, Coronary Aneurysm | Phase 2 | Active not recruiting | Hawaii Pacific Health | 26 | 2013-10-01 | 2026-06-03 |
| Trial of Atorvastatin on the Persistent Coronary Aneurysm in Children With Kawasaki Disease Atorvastatin - Kawasaki Disease, Aneurysm, Coronary | Phase 2 | Unknown | National Taiwan University Hospital | 20 | 2007-06-01 | 2014-04-15 |
| Prevention of Coronary Aneurysms in Kawasaki Syndrome immunoglobulins, intravenous, aspirin - Cardiovascular Diseases, Coronary Aneurysm | Phase 2 | Completed | National Heart, Lung, and Blood Institute (NHLBI) | 1985-07-01 | 2013-12-13 |
Mucocutaneous Lymph Node Syndrome (5) · Acute Coronary Syndrome (1) · Cardiovascular Diseases (1) · Heart Diseases (1)
Aneurysm (6) · Coronary Disease (6) · Myocardial Ischemia (6) · Vascular Diseases (6) · Cardiovascular Diseases (5) · Heart Diseases (5) · Hemic and Lymphatic Diseases (5) · Lymphatic Diseases (5) · Skin Diseases (5) · Skin Diseases, Vascular (5) · Skin and Connective Tissue Diseases (5) · Vasculitis (5)
Aspirin (2) · Immunoglobulins, Intravenous (2) · Atorvastatin (1) · Clopidogrel (1) · Doxycycline (1) · Infliximab (1) · Interleukin 1 Receptor Antagonist Protein (1) · Rivaroxaban (1) · Tablets (1) · canakinumab (1)
Assistance Publique - Hôpitaux de Paris (1) · Hawaii Pacific Health (1) · Instituto Nacional de Cardiologia Ignacio Chavez (1) · National Heart, Lung, and Blood Institute (NHLBI) (1) · National Taiwan University Hospital (1) · Novartis Pharmaceuticals (1)
France (1) · Mexico (1) · Taiwan (1) · United States (1)
Alexandra Arias Mendoza, MD (1) · Andras Bratincsak, MD PhD (1) · Diego Araiza Garaygordobil, MD, MSc (1) · Fred Rosen (1) · Ming-Tai Lin, MD (1)
PMID 29313803, PMID 32779863, PMID 35904750, PMID 39615618
2014 (1), R01HL034545 (1)